治疗新靶点

2.3 HER2驱动非小细胞肺癌(NSCLC):潜在的治疗路径

Published at: 2014年第1卷第11期

Ana Christina Garrido-Castro 1 , Enriqueta Felip 1
1 Medical Oncology Department, Vall d’Hebron University Hospital, Barcelona, Spain
请购买后进行阅读
comments powered by Disqus